High blood pressure is one of the most common health problems in the world. It affects millions of people and is often called a “silent killer” because it can damage the body for years without causing obvious symptoms.
If blood pressure stays too high for a long time, it can increase the risk of heart attacks, strokes, kidney disease, and other serious health conditions.
Because high blood pressure is so common, many people rely on medication to keep it under control. One widely prescribed group of medicines is known as L-type calcium channel blockers, or LCCBs. These drugs are designed to relax blood vessels, making it easier for blood to flow through the body and reducing the workload on the heart.
For many years, LCCBs have been considered an effective treatment option for hypertension. However, a new study from researchers at Penn State and several collaborating institutions suggests that these medications may not be as harmless as previously thought.
The research, led by Dr. Mohamed Trebak and published in the journal Proceedings of the National Academy of Sciences (PNAS), found evidence that LCCBs may increase the risk of heart failure in some patients, despite their ability to lower blood pressure.
High blood pressure affects nearly half of adults in the United States, representing more than 100 million people. Globally, the number of people living with hypertension continues to rise and is expected to exceed 1.5 billion. As a result, understanding the long-term effects of blood pressure medications is extremely important.
LCCBs work by blocking the movement of calcium into certain muscle cells found in blood vessel walls. These cells, known as vascular smooth muscle cells, control how wide or narrow blood vessels become.
When calcium enters the cells, the muscles contract, causing blood vessels to narrow. When calcium is blocked, the muscles relax, allowing blood vessels to widen and blood pressure to decrease.
Scientists originally believed that blocking calcium would not only lower blood pressure but also help prevent damage to blood vessels. In people with hypertension, excess calcium activity can cause blood vessels to become thicker and stiffer over time.
This process, called vascular remodeling, can make blood pressure even harder to control and place additional strain on the heart.
The new study found that the situation may be more complicated. Although LCCBs successfully block calcium and reduce blood pressure, the researchers discovered that the drugs may trigger blood vessel remodeling through a different biological pathway.
In other words, the medicines may still contribute to harmful changes in blood vessels even while performing their intended job.
To investigate this possibility, the research team conducted a series of laboratory experiments using cells and animal models. They also examined medical records from patients treated at Penn State.
The results consistently suggested that people taking LCCBs had a greater likelihood of developing heart failure compared with patients using other types of blood pressure medications.
Heart failure occurs when the heart becomes unable to pump blood efficiently throughout the body. It does not mean the heart suddenly stops working, but rather that it gradually becomes weaker and less effective. Symptoms can include shortness of breath, fatigue, swelling in the legs, and difficulty performing everyday activities.
The researchers believe their findings may have important implications for patient care. They suggest that doctors should carefully consider which blood pressure medication is most appropriate for each individual patient. Older adults and people with severe hypertension may require especially close monitoring.
The study also highlighted concerns about patients who are taking LCCBs and become infected with COVID-19. Since the virus can damage blood vessels and affect cardiovascular health, the combination of existing vascular changes and infection may increase risks for certain individuals.
Despite these findings, patients should not stop taking prescribed medications without consulting their healthcare provider. Blood pressure control remains essential for preventing serious complications, and treatment decisions should always be made with professional medical guidance.
Researchers emphasize that more studies are needed to fully understand the relationship between LCCBs, blood vessel remodeling, and heart failure. Future research may help identify which patients are most likely to benefit from these drugs and which may need alternative treatments.
The findings also remind us that medications can have complex effects on the body. A drug may successfully treat one problem while creating unexpected changes elsewhere. Continued research is therefore essential to ensure that treatments remain both safe and effective.
As scientists learn more about how blood pressure medicines affect the cardiovascular system, doctors may eventually be able to develop more personalized treatment strategies that control blood pressure while minimizing long-term risks.
For the millions of people living with hypertension, such advances could lead to safer and more effective care in the future.
If you care about high blood pressure, please read studies about unhealthy habits that may increase high blood pressure risk, and drinking green tea could help lower blood pressure.
For more information about high blood pressure, please see recent studies about what to eat or to avoid for high blood pressure, and 12 foods that lower blood pressure.
Copyright © 2026 Knowridge Science Report. All rights reserved.
